Latka logo
MBX Biosciences logo

MBX Biosciencesrevenue & market cap

Carmel, IndianaFounded 2019

Public company

MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders.

mbxbio.comLinkedInUpdated Sep 28, 2026
Annual revenue
Not disclosed
No public figure yet
Market cap
$2.8B
Sep 2026

MBX Biosciences revenue

MBX Biosciences has not published its revenue, and GetLatka has no sourced estimate yet. Know the figure? Send us a source.

MBX Biosciences market cap

MBX Biosciences is a public company. Its market capitalisation was $2.8B in September 2026.

Categories

How this page is sourced

Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Sep 28, 2026Data disclaimerReport a correctionClaim this profileRun MBX Biosciences? Join the podcast